Dr. Rita Nanda, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
About Rita Nanda, MD
Education:
Received MD from the University of Chicago Pritzker School of Medicine.
Experience:
Has been practicing since 2005.
Principal investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the I-SPY 2 trial.
Leads the University of Chicago Medicine's breast cancer clinical trial program.
Research focuses on new treatments for advanced breast cancer, with funding from notable organizations.
Board-certified in Medical Oncology.
Area of expertise
Breast Cancer
Rita Nanda, MD has run 23 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Rita Nanda, MD has run 8 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
University Of Chicago Medical Center
Clinical Trials Rita Nanda, MD is currently running
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting
1 award
Phase 2
15 criteria
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting
1 award
Phase 2
18 criteria
More about Rita Nanda, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Rita Nanda, MD has experience with
- Pembrolizumab
- Trastuzumab
- Mifepristone
- Atezolizumab
- Sacituzumab Govitecan
- Olaparib
Breakdown of trials Rita Nanda, MD has run
Breast Cancer
Breast cancer
Pancreatic Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rita Nanda, MD specialize in?
Rita Nanda, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Rita Nanda, MD currently recruiting for clinical trials?
Yes, Rita Nanda, MD is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Rita Nanda, MD has studied deeply?
Yes, Rita Nanda, MD has studied treatments such as Pembrolizumab, Trastuzumab, Mifepristone.
What is the best way to schedule an appointment with Rita Nanda, MD?
Apply for one of the trials that Rita Nanda, MD is conducting.
What is the office address of Rita Nanda, MD?
The office of Rita Nanda, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.